← Back
Data updated: Jul 17, 2026
VALEANT PHARMS
Generics Pharmaceuticals
VALEANT PHARMS is a generic drug manufacturer with 3 FDA-approved products.
1979
Since
3
Drugs
-
Trials
0
New Drugs (2yr)
VALEANT PHARMS's Key Drugs
VALEANT PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
VALEANT PHARMS's Recent FDA Approvals
New NDA/BLA approvals for VALEANT PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
VALEANT PHARMS's Therapeutic Areas
Disease areas where VALEANT PHARMS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
VALEANT PHARMS Pipeline Snapshot
Active clinical trials for VALEANT PHARMS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1979-01-08
- Latest
- 2018-01-29
- Applications
- 4
FDA Sponsor Names
VALEANT PHARMSVALEANT PHARMS LLC